Fagron SA header image

Fagron SA

FAGR

Equity

ISIN BE0003874915 / Valor 3425437

Euronext - Euronext Brussels (2026-07-07)
EUR 24.05-0.82%

Fagron SA
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Fagron SA is a prominent player in the pharmaceutical industry, specializing in pharmaceutical compounding, which involves creating personalized medication solutions tailored to individual patient needs. The company operates in a knowledge-intensive niche market, focusing on enhancing personalized medicine by collaborating closely with prescribers and pharmacists. Fagron's global initiative, Formulary, provides a wide array of customized formulas that cater to specific medical indications, thereby supporting healthcare professionals in delivering tailored treatment options. Additionally, Fagron emphasizes education and training through its Fagron Academies, which are established in various countries to inform and train healthcare providers about the intricacies of compounding. This strategic approach underscores Fagron's commitment to improving patient health outcomes by making personalized medicine more accessible.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

9.07%1Y
52.9%3Y
32.7%5Y

Performance

19.1%1Y
19.9%3Y
24.3%5Y

Volatility

Market cap

2008 M

Market cap (USD)

Daily traded volume (Shares)

49,945

Daily traded volume (Shares)

1 day high/low

16.76 / 16.58

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Asker Healthcare Group AB
Asker Healthcare Group AB Asker Healthcare Group AB Valor: 143378021
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.67%SEK 83.20
Alkem Laboratories Ltd.
Alkem Laboratories Ltd. Alkem Laboratories Ltd. Valor: 30689895
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.20%INR 5,664.75
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB Valor: 2676862
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.04%SEK 479.80
Indivior PLC
Indivior PLC Indivior PLC Valor: 121550831
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.93%GBP 30.52
Spire Healthcare Group PLC
Spire Healthcare Group PLC Spire Healthcare Group PLC Valor: 24881418
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.23%GBP 2.17
Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA Fresenius SE & Co. KGaA Valor: 332902
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.49%EUR 43.41
L'Oreal S.A.
L'Oreal S.A. L'Oreal S.A. Valor: 502805
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.74%EUR 388.35
MPH Health Care AG
MPH Health Care AG MPH Health Care AG Valor: 57233620
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.34%EUR 29.30
2invest AG
2invest AG 2invest AG Valor: 110098281
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 8.24
The Platform Group AG
The Platform Group AG The Platform Group AG Valor: 57796644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.67%EUR 0.89